Rapid DNA extraction protocol for detection of alpha-1 antitrypsin deficiency from dried blood spots by real-time pcr

Advances in Experimental Medicine and Biology

Volumn 756, Issue , 2013, Pages 29-37

  Struniawski, R ^a   Szpechcinski, A ^a   Poplawska, B ^a   Skronski, M ^a   Chorostowska Wynimko, J ^a  

^a NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

Author keywords

Alpha1 antitrypsin deficiency; Dried blood spot; Genotyping; Real time PCR; Screening

Indexed keywords

ALPHA 1 ANTITRYPSIN; GENOMIC DNA;

ALPHA 1 ANTITRYPSIN DEFICIENCY; CLINICAL PROTOCOL; CODON; CONFERENCE PAPER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA EXTRACTION; DRIED BLOOD SPOT TESTING; GENE AMPLIFICATION; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; ISOELECTRIC FOCUSING; MAJOR CLINICAL STUDY; NEPHELOMETRY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; VALIDATION PROCESS; WILD TYPE;

EID: 84867502602     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-4549-0_5     Document Type: Conference Paper

References (21)

1. American Thoracic Society/European Respiratory Society Statement. (2003). Standards for the diagnosis and management of individuals with alpha-1 antitrypsin de fi ciency. American Journal of Respiratory and Critical Care Medicine, 168 , 818-900.
2. Blanco, I., de Serres, F. J., Fernandez-Bustillo, E., Lara, B., & Miravitlles, M. (2006). Estimated numbers and prevalence of PI*S and PI*Z alleles of alpha-1 antitrypsin de fi ciency in European countries. European Respiratory Journal, 27 , 77-84.
3. Bornhorst, J. A., Procter, M., Meadows, C., Ashwood, E. R., & Mao, R. (2007). Evaluation of an integrative diagnostic algorithm for the identi fi cation of people at risk for alpha-1 antitrypsin de fi ciency. American Journal of Clinical Pathology, 128 , 482-490.
4. Brantly, M. (2006). Ef fi cient and accurate approaches to the laboratory diagnosis of alpha1-antitrypsin de fi ciency: The promise of early diagnosis and intervention. Clinical Chemistry, 52 , 2180-2181.
5. Caggana, M., Conroy, J. M., & Pass, K. A. (1998). Rapid, ef fi cient method for multiplex ampli fi cation from fi lter paper. Human Mutation, 11 , 404-409.
6. Chorostowska-Wynimko, J., Nizankowska-Mogilnicka, E., & The Working Group of the Polish Respiratory Society. (2010). Diagnosis and treatment of patients with alpha-1 antitrypsin (alpha-1 AT) de fi ciency. Pneumonologia i Alergologia Polska, 78 , 348-355.
7. Costa, X., Jardi, R., Rodriguez, F., Miravitlles, M., Cotrina, M., Gonzalez, C., Pascual, C., & Vidal, R. (2000). Simple method for alpha1-antitrypsin de fi ciency screening by use of dried blood spot specimens. European Respiratory Journal, 15 , 1111-1115.
8. DeMeo, D. L., & Silverman, E. K. (2004). Alpha-1 antitrypsin de fi ciency 2: Genetic aspects of alpha-1 antitrypsin de fi ciency: Phenotypes and genetic modi fi ers of emphysema risk. Thorax, 59 , 259-264.
9. Ferrarotti, I., Zorzetto, M., Scabini, R., Mazzola, P., Campo, I., & Luisetti, M. A. (2004). Novel method for rapid genotypic identi fi cation of alpha-1 antitrypsin variants. Diagnostic Molecular Pathology, 13 , 160-163.
10. Ferrarotti, I., Scabini, R., Campo, I., Ottaviani, S., Zorzetto, M., Gorrini, M., & Luisetti, M. (2007). Laboratory diagnosis of alpha-1 antitrypsin de fi ciency. Translational Research, 150 , 267-274.
11. Global Initiative for Chronic Obstructive Lung Disease (GOLD). (2010). Global strategy for diagnosis, management, and prevention of COPD (update), http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management. html
12. Jeppsson, J. O., & Franzén, B. (1982). Typing of genetic variants of alpha-1 antitrypsin by electrofocusing. Clinical Chemistry, 28 , 219-225.
13. Kaczor, M. P., Sanak, M., Libura-Twardowska, M., & Szczeklik, A. (2007). The prevalence of alpha-1-antitrypsin de fi ciency in a representative population sample from Poland. Respiratory Medicine, 101 , 2520-2525.
14. Laurell, C. B., & Sveger, T. (1975). Mass screening of newborn Swedish infants for alpha-1 antitrypsin de fi ciency. American Journal of Human Genetics, 27 , 213-217.
15. McDade, T. W., Williams, S., & Snodgrass, J. J. (2007). What a drop can do: Dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography, 44 , 899-925.
16. Ortiz-Pallardo, M. E., Ko, Y., Sachinidis, A., Vetter, H., Fischer, H. P., & Zhou, H. (2000). Detection of alpha-1 antitrypsin PiZ individuals by SSCP and DNA sequencing in formalin-fi xed and paraf fi n-embedded tissue: A comparison with immunohistochemical analysis. Journal of Hepatology, 32 , 406-411.
17. Rodriguez, F., Jardí, R., Costa, X., Cotrina, M., Galimany, R., Vidal, R., & Miravitlles, M. (2002). Rapid screening for alpha-1 antitrypsin de fi ciency in patients with chronic obstructive pulmonary disease using dried blood specimens. American Journal of Respiratory and Critical Care Medicine, 166 , 814-817.
18. Snyder, M. R., Katzmann, J. A., Butz, M. L., Wiley, C., Yang, P., Dawson, D. B., Halling, K. C., Highsmith, W. E., & Thibodeau, S. N. (2006). Diagnosis of alpha-1 antitrypsin de fi ciency: An algorithm of quanti fi cation, genotyping, and phenotyping. Clinical Chemistry, 52 , 2236-2242.
19. Stolk, J., Seersholm, N., & Kalsheker, N. (2006). Alpha-1 antitrypsin de fi ciency: Current perspective on research, diagnosis, and management. International Journal of COPD, 1 , 151-160.
20. Tazelaar, J. P., Friedman, K. J., Kline, R. S., Guthrie, M. L., & Farber, R. A. (1992). Detection of alpha-1 antitrypsin Z and S mutations by polymerase chain reaction-mediated site-directed mutagenesis. Clinical Chemistry, 38 , 1486-1488.
21. Zorzetto, M., Russi, E., Senn, O., Imboden, M., Ferrarotti, I., Tinelli, C., Campo, I., Ottaviani, S., Scabini, R., von Eckardstein, A., Berger, W., Brändli, O., Rochat, T., Luisetti, M., Probst-Hensch, N., & SAPALDIA Team. (2008). SERPINA1 gene variants in individuals from the general population with reduced alpha-1 antitrypsin concentrations. Clinical Chemistry, 54 , 1331-1338.